On September 8, 2020 Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, reported that Aoife Brennan, M.B. Ch.B., Synlogic’s president and chief executive officer, and other members of the executive team will present at the following virtual banking conferences (Press release, Synlogic, SEP 8, 2020, View Source [SID1234564739]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

HC Wainwright 22nd Annual Global Investor Conference: The Company will present at 12:00 noon on Tuesday, September 15, 2020.
Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit: The Company will present at 4.10 pm on Wednesday, September 23, 2020
Jefferies IBD Therapeutics Summit: The Company will present at a time to be determined on Wednesday, September 23, 2020.
These are virtual events. A live webcast of the presentations can be accessed under "Event Calendar" in the Investors & Media section of the Company’s website. An archived copy of the webcast will be available on the Synlogic website for approximately 30 days after the event.